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Outpatient echocardiography as a predictor 
of perioperative cardiac morbidity after 
peripheral vascular surgical procedures 
Kenneth Ouriel, MD, Richard M. Green, MD, James A. DeWeese, MD, and 
Maurice E. Varon, MD, Rochester, N.Y. 
Purpose: A variety of preoperative provocative t sts have been used to define the risk of 
cardiac morbidity and mortality after peripheral vascular procedures, including dipyri- 
damole myocardial scintigraphy and dobutamine stress echocardiography. Although 
highly sensitive, these tests are time-consuming and associated with signißcant expense. 
We investigated outpatient echocardiography as a less resource-intensive means of 
assessing cardiac risk with operation. 
Methods: Over a 2-year period 250 consecutive patients tmderwent outpatient transtho- 
racic echocardiography before elective peripheral vascular operation was performed. The 
accuracy of the Goldman, Detsky, and the American Society ofAnesthesiologists' Physical 
Status Classification clinical indexes of cardiac risk were assessed with regard to the 
development of cardiac complications such as unstable angina, myocardial infarction, 
life-threatening ventricular arrhythmias, evere congestive heart failure, and cardiogenic 
shock. The accuracy of echocardiographically determined left ventricular ejection fraction 
was determined atthreshold values between 20% and 60%. 
Results: Perioperative cardiac events developed in 23 (9.2%) of the patients, and nine 
(3.6%) of the patients died as a result of these complications. Clinical indexes lacked 
sensitivity in the preoperative prediction of cardiac complications. Receiver operating 
curve analysis defined aleft ventricttlar ejection fraction ofless than 50% as an appropriate 
threshold for defining patients at high risk, with a sensitivity of 78% and a specificity of 
81% in the idenUfication of patients who had cardiac morbidity. The positive predictive 
value was 27%, and the negative predictive value was 97%. The economic impact of 
outpatient echocardiography was weil below that of dipyridamole myocardial scintigraphy 
or dobutamine stress echocardiography. 
Conclusions: Outpatient echocardiography appears to offer a cost-efficient compromise 
between clinical criteria alone and provocative cardiac testing such as dipyridamole 
myocardial scintigraphy and dobutamine stress echocardiography in the preoperative 
screening of patients undergoing peripheral vascular surgical procedures. (J VAsc SURG 
1995;22:671-9.) 
Peripheral vascular operations are highly invasive 
interventions that are frequently performed in medi- 
cally compromised patients.~ It is not surprising that 
cardiac omplications rank highest among the causes 
of perioperative morbidity. The potential benefits of 
elective procedures must be weighed against the risk 
of perioperative complications, with therapeutic 
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decisions based on estimates of perioperative risk. 
The patient care team should be adequately informed 
of the patient's baseline cardiac status to plan and 
execute such perioperative interventions as the type 
of anesthesia, the use ofinvasive monitoring, and the 
occasional need for antecedent coronary revascular- 
ization. 
A variety ofparameters have been used to predict 
the risk of cardiac omplications with peripheral vas- 
cular surgical procedures. Clinical indexes have been 
moderately successful in predicting risk, relying on a 
history of cardiac events and elcctrocardiographic or 
laboratory abnormalities. 2,3Clinical criteria lone, 
however, tend to underestimate risk in patients un- 
dergoing major peripheral vascular operations, pri- 
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Table I. Perioperative cardiac omplications 
Patients Mortality rate 
Event (%) (%) 
Congestive heart failure 11 (4.4) 3 (27) 
Myocardial infarction 18 (7.2) 6 (33) 
Unstable angina 4 (1.6) 0 
Life-threateningventricular 2 (0.8) 1 (50) 
arrhythmia 
Cardiogenic shock 6 (2.4) 5 (83) 
Any of the above 23 (9.2) 9 (39) 
marily because the indexes were derived from patients 
undergoing eneral surgical procedures. 4 Tests of 
myocardial reserve such as dipyridamole-thallium 
scintigraphy, s-7 dobutamine echocardiography, 8,9 
and eren coronary angiography 1°,11 have been used to 
increase sensitivity. Although informative, these tests 
are mildly to moderately invasive, time-consuming, 
and expensive, s Transthoracic echocardiography is a 
simpler procedure that is easily performed in the out- 
patient setting. We evaluated preoperative echocardi- 
ography as a method to predict perioperative cardiac 
events, tabulating dinical outcome and economic 
costs in an unselected series of patients undergoing 
peripheral vascular procedures. 
METHODS 
The study group consisted of 250 consecutive 
patients undergoing elective peripheral vascular sur- 
gical procedures between January 1, 1993, and 
December 31, 1994. Patients were subdivided with 
respect to the major procedure performed: aortic (42 
patients), carotid (57 patients), or infrainguinal (123 
patients). Patients not falling into one of the three 
categories were grouped into a miscellaneous cat- 
egory that included major lower extremity amputa- 
tions (15), renal artery reconstructive procedures (8), 
and upper extremity arterial reconstructions (5). A 
thorough cardiac history was obtained from each 
patient, tabulating the American Society of Anesthe- 
siologists' Physical Status Classification (ASA) 
grade, 12 the Goldman multifactorial index of cardiac 
risk, 2 and the Detsky in&x? Twelve-lead electrocar- 
diograms were obtained and compared with previous 
tracings when available. Two-dimensional surface 
echocardiography with color Doppler spectral anal- 
ysis was performed before operation in each patient 
(Ultramark 9-HDI, A.T.L., Inc., Bellvue, Wash. or 
Sonos 1000, Hewlett Packard Co., Andover, Mass.). 
The studies were done within 2 weeks of operation, 
recorded on videotape, and read by an experienced 
cardiologist. Echocardiographic assessment i cluded 
a measuremcnt of he left ventricular ejection fraction 
(LVEF), observation of valvular abnormalities, wall 
motion abnormalities, and intracardiac thrombus. 
No patient underwent coronary angiography, 
angioplasty, or bypass before the peripheral vascular 
procedurc was done. Abnormal echocardiographic 
findings, however, were made available to the anes- 
thesia team and modified the planned perioperative 
monitoring approach with respect o the use of 
pulmonary artery catheters and intraoperative trans- 
esophageal echocardiography. 
Perioperative events were those events that oc- 
curred within 30 days of operation. Cardiac enzymes 
were assessed after operation and daily for 72 hours 
when possible. Electrocardiograms were obtained 
after operation and daily for 2 days. Cardiac ompli- 
cations included unstable angina, myocardial infarc- 
tion, lifc-threatening vcntricular arrhythmias, evere 
congestive heart failure, and cardiogenic shock. 
Unstable angina was diagnosed if all three of the 
following criteria were mer: (1) chest discomfort at 
rest, (2) 1 mm or greater ST-segment depression i
two or more leads, and (3) relief of symptoms with 
antianginal medication. Myocardial infarction was 
diagnosed if two or more of the following criteria 
were met: (1) more than 30 minutes ofanginal chest 
discomfort, (2) electrocardiographic ST-segment el- 
evation with new Q-waves or T-wave inversions, (3) 
elevated creatinine kinase levels with an MB fraction 
greater than 5%, or (4) new resting wall mofion 
abnormalities in two or more of the 18 segments 
compared with the preoperative echocardiogram. 
Life-threatening ventricular arrhythmias included 
ventricular tachycardia nd ventricular fibrillation. 
The diagnosis of congestive heart failure required a
significant increase in the arterial-alveolar g adient 
and radiographic findings of left heart failure. Car- 
diogenic shock was diagnosed when reductions in 
cardiac output were associated with the failure to 
maintain a mean systemic blood pressure greater than 
70 mm Hg. Cardiac-related mortality was defined as 
those deaths that could be direcfly attributed to 
myocardial events. Patients were monitored for a 
mean of 12 + 3 months after operation. Late post- 
operative cardiac events and cardiac-related mortality 
were tabulated, as were deaths from noncardiac 
causcs. 
Statistical methods included analysis of variance 
techniques for continuous variables, the chi-squared 
test with the Pearson eoefficient for dichotomous 
variables, Kaplan-Meier life-table methods for een- 
sored data, ~3 and receiver operating curvc analysis to 
analyze the predictive value of a test over the 
spectrum of threshold values. 14,~s Sensitivity and 
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Table II. Major cardiac omplication rates with respect to operative procedure and multifactorial 
cardiac risk index 2
Aortic operation Carotid operation Infrainguinal bypass Other All procedures 
Goldman class (%) (%) (%) (%) (%) 
Class I 1/12 (8.3) 0/23 (0) 3/38 (7.9) 1/12 (8.3) 5/85 (5.9) 
Class II 1/19 (5.3) 0/18 (0) 4/59 (6.8) 0/8 (0) 5/104 (4.8) 
Class III 1/11 (10) 2/15 (13) 5/19 (26) 1/8 (13) 9/53 (17) 
Class IV 0 0/1 (0) 4/7 (57) 0 4/8 (50) 
Total 3/42 (7.1) 2/57 (3.5) 16/123 (13) 2/28 (7.1) 23/250 (9.2) 
Table III. Frequency of perioperative cardiac omplications and heart-related deaths tabulated by 
type of procedure 
Cardiac omplications 
Procedure Patients (%) Cardiac mortality 
Aortic 42 3 (7.1) 1/42 (2.4) 
Carotid 57 2 (3.5) 0 
Infraingttinal 123 16 (13) 2 7 (5.7) 0~ 
Other 28 2 (7.1) 1 (3.6) 
~,0 = 0.05. 
specificity were calculated for each test, as were the 
positive and negative predictive values. 16 Economic 
impact was specified in 1995 U.S. dollars with the 
Medicare Part-B allowable rates for the global 
(technical nd professional) charge for the Rochester, 
New York area. Values were expressed as mean + 
SEM for normally distributed data and as median and 
interquartile (25th to 75th percentile) range for 
nonparametric data. Significance was assumed when 
the two-tailedp value was less than 0.05. 
RESULTS 
Preoperative fmdings. The mean age of the 188 
men and 62 women was 69 +- 3 years, with a range 
of 36 to 95 years. Hypertension was present in 131 
(52%) patients, and hyperlipidemia was present in 
112 (45%) patients. A history of myocardial infarc- 
tion was present in 71 (28%) patients, and 52 (21%) 
patients had undergone a previous coronary artery 
bypass procedure. A tobacco hismry was elicited in 
199 (80%) patients, 73 (29%) patients had diabetes, 
and 19 patients had dialysis-dependent renal insuffi- 
ciency. Only 18 (7%) patients had no history of 
tobacco use, diabetes, or end-stage r nal failure. No 
significant differences were seen in the frequency of 
comorbid conditions between patients undergoing 
aortic, carotid, or infrainguinal operations. 
Patient morbidity and mortality. A total of 23 
(9.2%) of the patients had perioperative cardiac 
morbid events (Table I), occurring a median of 2.2 
days (interquartile range 1.2 to 6.1 days) after 
operation. No differences were seen in the time 
interval between operation and cardiac omplications 
with respect to the type of vascular procedure 
performed or the sex of the patient. Perioperative 
cardiac deaths occurred in nine (3.6%) of the patients 
a median of 5.9 days (interquartile fange 3.8 to 11.9 
days) after operation. Three noncardiac perioperative 
deaths occurred in the series; two were the result of 
pulmonary failure, and one was the result of over- 
whelming sepsis. Patient survival at 6 and 12 months 
was 92% _+ 3% and 88% -+ 3%, respectively. 
The distribution of cardiac morbidity is depicted 
in Table II, stratified by Goldman class. A signifi- 
cantly higher incidence of cardiac morbid events 
occurred in patients undergoing infrainguinal bypass 
procedures compared with those undergoing other 
procedures (Table III, p = 0.05). Cardiac deaths 
occurred more frequently in patients undergoing 
infrainguinal bypass procedures when compared 
with patients undergoing aortic or carotid proce- 
dures (p = 0.05). 
Clinical predictors of cardiac risk. The three 
clinical risk scales that were evaluated were imprecise 
in the identification ofpatients who had perioperative 
cardiac omplications, with sensitivities ranging from 
26% to 57% (Table IV). The clinical indexes 
appeared to be relatively specific, however, with 
degrees of specificity ranging from 79% to 87%. 
Whereas the negative predictive values of the indexes 
were relatively high (91% to 94%), the large number 
ofpatients within the high-risk clinical strata who did 
not have cardiac morbidity rendered the positive 
predictive values poor (17% to 22%). 
IOURNAL OF VASCULAR SURGERY 
674 Ouriel et al. December 1995 
Table IV. Sensitivity and specificity of clinical scales in the prediction of perioperative 
cardiac events 
Sensitivity Specificity Positive predictive value Negative predictive value 
(%) (%) (%) (%) 
ASACIass >-3 11/23 (48) 187/227 (82) 11/51 (22) 187/199 (94) 
Goldman index > 12 points 13/23 (57) 179/227 (79) 13/61 (21) 179/189 (95) 
Detsky index > 16 points 6/23 (26) 198/227 (87) 6/35 (17) 198/215 (92) 
Table V. Sensitivity and specificity of echocardiographic findings in the identification of patients 
with perioperative cardiac events 
Patients (%) Sensitivity (%) Specificity (%) 
Valve abnormalities ö2 (25) 30 76 
Mural thrombus 12 (5) 22 97 
Resting wall motion abnormalities 40 (16) 52 88 
Left ventricular ejection fraction < 50% 66 (26) 78 81 
Echocardiography as a predictor of cardiac 
risk. The echocardiographic findings that were poor 
predictors of cardiac complications included the 
presence of valvular abnormalities, resting wall mo- 
tion abnormalities, and mural thrombus (Table V). 
By contrast, LVEF was an important predictor of 
cardiac morbidity and mortality (Table VI). All four 
patients with LVEF less than 20% had perioperative 
cardiac complications, two of which were fatal. 
Cardiac events were infrequent in patients with 
LVEF of 50% or more, however, occurring in only 
5 (2.7%) of 184 patients. The perioperative mortality 
rate was only 0.5% in the group of patients with 
LVEF equal to or greater than 50%. Receiver 
operating curve analysis identified an LVEF of 50% 
as an acceptable threshold for predicting the devel- 
opment of cardiac complications (Fig. 1), with a 
sensitivity of 78% and a specificity of 81%. The 
calculated positive predictive value was 27%, sug- 
gesting that more than one fourth ofpatients with an 
LVEF less than 50% would be expected to have a 
cardiac complication after undergoing a peripheral 
vascular surgical procedure. The negative predictive 
value was 97%, suggesting that all but a small fraction 
of patients with LVEF greater than 50% could be 
expected to undergo peration tmeventfially. With a 
threshold LVEF of 50% to predict he development 
of cardiac omplications, the relative risk values for 
echocardiography were compared with the ASA, 
Goldman, and Detsky indexes (Table VII). Echocar- 
diography was the most accurate predictor of cardiae 
complications compared with the three clinical in- 
dexes (p = 0.04). 
When cardiac morbid events occurred, they were 
more likely to result in death when the preoperativc 
LVEF was low (p = 0.03). The risk ofdeath from a 
myocardial complication was 50% (7 of 14) when the 
LVEF was less than 40%, 25% (1 of 4) when the 
LVEF was between 40% and 50%, and 20% (1 of 5) 
when the LVEF was 50% or more. 
Economic analysis of preoperative echocardi- 
ography. The economic burden ofscreening the 250 
patients in the series was $51,295, or approximately 
$205 per patient evaluated. With a threshold LVEF 
of 50% to identify patients at high risk for cardiac 
morbidity, the charges were $777 per individual 
identified as being at high risk and $2850 per cardiac 
event correctly predicted. 
DISCUSSION 
Complications of coronary artery disease remain 
the leading cause of death after peripheral vascular 
surgical procedures. ~7-19 Cardiac complications de- 
veloped in 9% of the patients undergoing elective 
peripheral vascular procedures in this seiles. More 
than one third of these culminated in death, usually 
within a week of operation. The risk of perioperative 
cardiac omplications and cardiac-related death was 
closely associated with LVEF as determined by 
preoperative outpatient echocardiography. With a 
threshold LVEF of 50%, approximately one fourth 
of patients undergoing peripheral vascular surgical 
procedures were identified as being at risk for a 
perioperative cardiac event, and one fourth of these 
patients actually had an event. Of the three fourths of 
patients not identified as being at high risk, only 3% 
had a cardiac event. 
Other investigators have documented similar 
risks of cardiac-related morbidity and death after 
peripheral vascular procedures. 5,6,9,17'18'2°,21 The inci- 
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dence appears to be highest after infrainguinal nd 
aortic procedures and somewhat lower after carotid 
endarterectomy. 22'23 We reported a 7% cardiac om- 
plication rate in a previous investigation, 8 corre- 
sponding closely with the 9% rate observed in this 
study. Corroborating the data of previous investiga- 
tors, we found the highest incidence in patients 
undergoing infrainguinal rterial reconstruction a d 
the lowest in patients undergoing carotid endarter- 
ectomy. 5,6,9,2°,2z These data taust be evaluated in the 
context of symptomatic cardiac events, especiaily in 
the patients with carotid difficulties who were 
discharged within 2 days of operation, precluding 
prolonged cardiae nzyme analyses. 
Previous studies have documented similar find- 
ings with regard to perioperative risk and left 
ventricular ejection fraction. 4,7,18,21 Although many 
of these studies have used radionuclide ventriculog- 
raphy to determine ejection fraction, others have used 
echocardiography. Patients with severe left ventricu- 
lar dysfimction predictably had a high incidence of 
perioperative cardiac omplications. The sensitivity 
of the test, however, isdecreased asa result ofpatients 
with significant coronary artery disease that has not 
yet produced myocardial dysfunction. It appears that 
this clinical scenario occurs at a relatively low 
frequency, accounting for a sensitivity of resting 
echocardiography of 78%. 
The explanation for the high rate ofcardiac events 
in patients undergoing peripheral vascular surgical 
procedures is clear; the systemic nature of atheroscle- 
rotic disease makes this population uniquely suscep- 
tible to cardiac decompensation with the increased 
physiologic stress associated with operation. The 
frequency of clinically evident coronary artery disease 
has been reported to be more than 50% in patients 
undergoing peripheral vascular surgical procedures, 24 
and an additional one third have asymptomatic severe 
coronary disease, n,25 Whereas cardiac operations 
leave most patients with a well-perfused myocar- 
dium, peripheral vascuhr operations are associated 
with a similar degree of physiologic insult without 
the restorative effects of coronary revascularization. 
This observation may in part explain the higher 
cardiac mortality rate of peripheral vascular as op- 
posed to cardiac vascular operations. 
Three basic reasons exist to risk-stratify patients 
undergoing vascular surgical operations. The first is 
to identify cardiac problems that might be corrected 
with angioplasty or coronary artery bypass before the 
peripheral vascular procedure is performed. A second 
reason is to define the perioperative risks of major 
vascular operation so that these data may be factored 
Table VI. Cardiac events with respect to 
resting left ventricular ejection fraction 
Cardiac morbidity Cardiac mortality 
LVEF Pacients (%) (%) 
<20% 4 4 (100) 2 (50) 
20%-29% 12 4 (33) 1 (8) 
30%-39% 15 6 (40) 4 (27) 
40%-49% 35 4 (11) 1 (3) 
50%-59% 138 2 (1) 1 (1) 
-> 60% 46 3 (7) 0 
LVEF, Left ventricular ejection ffaction. 
into the risk-benefit equation presented tothe patient 
when he or she is choosing between various thera- 
peutic options. A third purpose is to identify patients 
who might benefit from perioperative invasive moni- 
toring such as preoperative maximization of left 
ventrieular ftmction with a pulmonary artery catheter 
or intraoperative transesophägeal chocardiography. 
Clinical criteria such as the ASA class or the 
Goldrnan or Detsky index, although free from 
economic onus, are inaccurate predictors of cardiac 
risk in the peripheral vascular patient population, as 
documented in previons tudies 4,2°,22 and this inves- 
tigation. The asymptomatic nature of cardiac disease 
in a large number of patients undergoing peripheral 
vascular procedures has prompted the use of pro- 
vocative testing to uncover silent coronary artery 
disease. There exist four such tests that have under- 
gone extensive evaluation i the setting of peripheral 
vascular surgery: exercise stress testing, ambulatory 
Holter monitoring, dipyridamole-thallium redistri- 
bution, and dobutamine stress echocardiography. 
These tests were compared in a recent meta-analysis 
reported by Mantha et al. 22 The authors computed 
the "relative risk" for each test, an indëx of the 
positive predictive value of a test to the inverse of its 
negative predictive value. Relative risk allows the 
diagnostic abilities of different tests to be compared. 
For example, a relative risk of 5.0 implies that 
individuals with a positive test result have a risk of 
having a cardiac omplication that is five tirnes that of 
individuals with a negative test result. A relative risk 
of 1.0 implies that the risk is similar in patients with 
positive or negative test results. We observed a 
relative risk of 10.1 for outpatient echocardiography, 
a rate that is only moderately below that of dobuta- 
mine stress echocardiography 8,9 (relative risk 15.10) 
or dipyridamole myocardial scanning 6'26'27 (relative 
risk 17.03) but weil above that observed with the 
ASA, Goldman, or Detsky clinical indexes. 
The economic impact of outpatient echocardiog- 
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Fig. 1. Receiver operating curve for outpatient echocardiography in prediction of perioper- 
ative cardiac events. Labels opposite square symbols represent left ventricular ejection fraction 
associated with specific true-positive (test result positive, cardiac omplication occurred), 
false-positive (test result positive, no cardiac omplication occurred) coordinate. Triangular 
symbols denote fitted curve. 
Table VII. Relative risk values and 95% confidence intervals for cardiac screening indexes and 
tests, derived from the study data 
Test Criteria for a positive test result Relative risk 
ASA Class Class 3 3.66 (0.89-4.02) 
Goldman index Score greater than 12 2.33 (0.78-4.12) 
Detsky index Score greater than 16 2,13 (1.05-3.46) 
Echocardiography LVEF <50% 10,11 (4.92-20.77) 
LVEF, Left ventricular ejection fraction. 
raphy was performed at a relatively modest cost, 
amounting to $777 per patient identified as being at 
significant risk for perioperative cardiac morbidity 
and $2850 per individual identified who subse- 
quently had a cardiac event. The provocative tests 
were more sensitive than outpatient echocardiogra- 
phy but were associated with considerably greater 
economic burden. Dobutamine chocardiography, 
for example, had a sensitivity of 100% but was 
associated with charges of $2194 per patient identi- 
fied as being at risk for cardiac events and $11,850 per 
cardiac event correctly predicted when calculated 
from data in a recently reported study performed at 
our institution. 8 Screening dipyridamole myocardial 
scintigraphy is even more resource-intensive, with an 
economic impact of roughly twice that of dobuta- 
mine echocardiography at the University of Roches- 
ter. Bry et al. s calculated the economic burden of 
dipyridamole scintigraphy at slightly more than 
$3000 per patient screened and more than $14,000 
per patient identified as being at risk for cardiac 
morbidity, althongh these data include the charges 
for coronary angioplasty and cardiac operation in 
patients at high risk. Bry et al. concluded that 
dipyridamole scintigraphy may not be cost-effective 
in patients undergoing peripheral vascular surgical 
procedures. 
The clinical and economic justification of such 
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provocative screening tests as dipyridamole myocar- 
dial scintigraphy are based fundamentally on putative 
decreases in perioperative myocardial infarction and 
death with selective intervention. Few objective data 
exist documenting a decrement in mortality rate 
through the use of preoperative hemodynamic maxi- 
mization or selective coronary revascularization be- 
fore peripheral vascular operation. 28 The use of these 
semiinvasive tests becomes cost-prohibitive as the 
incidence of perioperative cardiac complications de- 
creases with contemporary perioperative manage- 
mentJ Outpatient echocardiography is clearly less 
sensitive than dipyridamole-thallium scanning or 
dobutamine stress echocardiography. Nevertheless 
important information is generated with regard to 
perioperative mortality rates, information that can- 
not be obtained from clinical criteria alone. These 
data are erucial to the physician and patient during 
the formulation of an appropriate management 
strategy, primarily to decidc whether the potential 
benefits of a particular procedure are outweighed by 
the cardiac risks. As health care decisions become 
increasingly determined by cost constraints, outpa- 
tient echocardiography may offer a less resource 
intensive means of estimating the cardiac risks 
associated with peripheral vascular surgical proce- 
dures. 
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DISCUSSION 
Dr. Jerry R. Youkey (Danville, Pa.). In the continuing 
search for the surgical grail of cardiac risk assessment, 
Ouriel and his colleagues at the University of Rochester 
have correlated preoperative echocardiographic left ven- 
tricular function with surgical outcome in a consecutive 
series of 250 patients undergoing peripheral vascular 
surgery. Through statistical analysis of their data they 
arrived at three not terribly starfling condusions: (1) 
patients with severely impaired ventricles tolerate major 
vascular surgery poorly; (2) patients with normal ventricles 
generally do well; and (3) most patients with mild to 
moderate ventricular impairment do weil, but many do not. 
While I agree that such categorization has clinical merit, it 
would appear from the information presented that ASA 
grade was roughly equivalent to resting echocardiography 
in regards to negative and positive predictive value. 
Furthermore it would seem to me that the value of such 
categorization is the identification of a subgroup ofpatients 
who are most likely to benefit from further definition and 
perhaps treatment of their ongoing ischemic burden. 
In April 1993 Langan presented before the Seventh 
Annual Meeting of The Eästern Vascular Society out 
Geisinger Medical Center experience prospectively using 
preoperative dobutamine stress echocardiography to treat 
patients undergoing abdominal aortic surgery. The strategy 
permitted elective aortic reconstruction to be performed in 
74 of 81 patients with no deaths and a 4.1% incidence of 
perioperative myocardial infarction. 
In September 1993 the Rochester group published 
similar data using dobutamine stress echocardiography to 
screen patients undergoing major vascular surgery. With 
this in mind I do not understand why the current study did 
not include a preoperative effort to identify among the 62 
patients with ejection fractions of 20% to 50% those who 
had ongoing stress-related ischemia. Such a strategy had 
the potential to affect he 25% major cardiac omplication 
rate and 12% cardiac mortality in this subgroup ofpatients. 
These observations lead me to the following questions. 
(1) From your data is not ASA grading more cost-effective 
and roughly equivalent o resting echocardiography in 
risk-stratifying these patients? 
(2) What would be your thoughts about a clinical 
strategy involving resting echocardiography only for pa- 
tients whose ASA class is greater than or equal to 3, 
dobutamine provocation for those with ejecnon fractions 
between 20% and 50%, and cardiac catheterization for 
those who demonstrate inducible ischemia? 
(3) Since the results of neither this study nor your 
previous effort were used in a prospective management 
algorithm, how are you currently evaluating and managing 
cardiac risk in your vascular surgical patients? 
(4) Do you have any data correlating long-term 
survival with the results of either resting echocardiograms 
or dobutamine stress echocardiography? 
The commentary of Dr. John Porter in the 1995 
Yearbook ofVascular Surgery reflects achange in his position 
from disbelief that preoperative cardiac risk stratification is 
possible to healthy skepticism about out ability to mean- 
ingfully affect he disease. He opines that, "We can certainly 
find it, but there is not much we can do about it." Until we 
have data demonstrating short-term clinical benefit and 
improved long-term survival by patient reatment involv- 
ing cardiac risk stratification, bis will appropriately remain 
the final word on such strategies. In closing I would like to 
thank the Society for inviting me to discuss this interesting 
work, and Dr. Ouriel for so promptly forwarding to me a 
copy of his excellent manuscript. 
Dr. Kenneth Ouriel (Rochester, N.Y.). Our clinical 
indexes, for example, the ASA criteria, were not as sensitive 
as the echocardiogram in predicting morbid events. A1- 
though the positive predictive values appeared similar, the 
sensitivity was rauch improved with echocardiography. We 
feel that the increased sensitivity of echocardiography 
justifies its use from the standpoint of risk stratification. 
With regard to a clinical paradigm that reserves further 
diagnostic workup for patients falling within the high-risk 
ASA categories, the lack of sensitivity of the clinical 
measures alone would result in missing more than one half 
of the patients who go on to have cardiac complications. 
Currently, we rely on resting echocardiography in the 
preoperative predication ofcardiac risk. As you have stated, 
we have written on the use of dobutamine stress echocar- 
diography and have reported excellent results with respect 
to sensitivity in identifying patients who subsequently have 
cardiac events. Dobutamine chocardiography, owever, is 
expensive and difficult to schedule. These issues have been 
instrumental in our present focus on outpatient resting 
echocardiography. Presently, we have little data on the 
association between the echocardiography results and 
long-term patient survival, hut these are data that we intend 
to accumulate and analyze with increased patient numbers 
and duration of foUow-up. 
Dr. Thomas F. O'Donnell, Jr. (Boston, Mass.). I 
enjoyed the article, but I am wondering whether you could 
clarify some issues for me. There was a clinical impact on 
selecting patients out for coronary intervention. Were any 
patients excluded? Were the patients treated in a blinded 
fashion with respect to the results of the echocardiogram? 
Dr. Ouriel. We did not treat our patients in a blinded 
fashion. The complexity of perioperative monitoring was 
modified by the resnlts of the preoperative chocardio- 
gram. No patient, however, underwent coronary arteriog- 
raphy, angioplasty, or bypass on the basis of the test. The 
lack ofcoronary interventions was primarily based on a lack 
ofobjective data documenting an improved outcome when 
coronary lesions are addressed before the peripheral 
vascular problem. 
Dr. O'Donnell. My second question relates to whether 
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you have sanitized your end points. Most contemporary 
studies do not include congestive heart failure and arrhyth- 
mia as hard end points. How did the positive predictive 
value of echocardiography change if you used myocardial 
infarction and death as the only end points? Did it drop 
dramatically? 
Dr. Ouriel. The end points that we used in this smdy 
were very similar to the end points we used in our previous 
report on the use of dobutamine stress echocardiography. 
Most of the complications were, in fact, "hard." Myocardial 
infarctions composed 18 of 23 events, although not all was 
transmural. 
Dr. Keith D. Calligaro (Philadelphia, Pa.). Ken, did 
you find that there was any difference in the positive 
predictive value when the patients were subcategorized by
type of operation? I realize a subgroup analysis would have 
decreased your patient nnmbers to very small levels, but I 
would make the plea that we should stop grouping carotid 
procedures with aortic procedures and infrainguinal by- 
passes. 
Dr. OurieF. Unformnately, the numbers do get small 
when wc subcategorizcd our obscrvations by type of 
operation. However, our data would suggest that thc type 
of operation had little effect on association between 
ejection fractions and the mortality rate. The data did 
corroborate the observations of Dr. Veith, with respect o 
the highest mortality rates in patients undergoing infrain- 
guinal rcconstructions. 
Dr. Enrico Ascer (Brooklyn, N.Y.). Despite a very 
crisp and elegant presentation, I remain somewhat con- 
fused about he message to take home. Should we perform 
echocardiography on these patients and monitor them 
without intervention, or should we perform coronary 
angiography on those with ejection fractions of less than 
50%? This smdy results parallel those of Drs. Riles and 
Imparato, published a few years ago. However, the 
message of those anthors was different. Are there legal 
issues when we do not study the coronaries of a patient with 
a low ejection fraction? 
Dr. Ouriel. Orte should not interpret out data to 
suggest hat screening echocardiography should be fol- 
lowed by coronary angioplasty or revascularization when 
the test results are "positive." Out prejudice is that coronary 
intervention before peripheral vascular procedures does not 
result in lower overall mortality. A comparison of two 
different reatment protocols requires the performance ofa 
controlled study. This question cannot be answered efini- 
tively until a series of patients is randomly allocated to 
echocardiography alone versus echocardiography followed 
by coronary intervention. In this regard, I would agree with 
the commcnts of Dr. Porter, suggesting that the echocar- 
diograrn should not be used in an attempt o isolate a 
subpopulation who might benefit from coronary interven- 
tions. Rather, we should use out preoperative tests to 
predict the risks of cardiac morbidity after peripheral 
vascular procedures, taking these data into consideration 
when we counsel the patient with respect to the risk/benefit 
ratio of a particular operation. 
